ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary Edema

This study has been completed.

Sponsored by: Hopital Lariboisière
Information provided by: Hopital Lariboisière
ClinicalTrials.gov Identifier: NCT00390442
  Purpose

In cardiogenic pulmonary edema, Continuous Positive Airway Pressure (CPAP) added to medical treatment improves outcome. The present study was designed to assess the benefit of CPAP as a first line treatment of cardiogenic pulmonary edema in the out-of-hospital environment.


Condition Intervention Phase
Cardiogenic Pulmonary Edema
Device: continuous positive airway pressure
Phase III

MedlinePlus related topics:   Edema   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Safety/Efficacy Study
Official Title:   Effect of Continuous Positive Airway Pressure as a First Line Therapy in Out-of-Hospital Management of Severe Cardiogenic Pulmonary Edema

Further study details as provided by Hopital Lariboisière:

Primary Outcome Measures:
  • Primary endpoint : effect of early CPAP on a dyspnea clinical score and on arterial blood gases.

Secondary Outcome Measures:
  • Secondary endpoints :
  • incidence of tracheal intubation,
  • inotropic support,
  • in-hospital mortality.

Detailed Description:

Cardiogenic pulmonary edema (CPE) is a frequent presenting process for acute out-of-hospital practice. Acute left heart failure may occur from a variety of processes that rapidly deteriorates to this generalized cardiopulmonary disorder. The classical treatment of out-of-hospital CPE includes supplemental oxygen, vasodilators, loop diuretics, and morphine. If not effective, or because of the associated respiratory depression, tracheal intubation and mechanical ventilation are often needed, which, by themselves are associated with a worse prognosis. Continuous positive airway pressure (CPAP) has been proposed as an alternative to mechanical ventilation in CPE. This technique not only improves alveolar recruitment and decreases the work of breathing 4 but also reduces left ventricular afterload, and both right and left ventricular preload. The overall effect of CPAP in the acute management of CPE is to improve cardio-respiratory function and sustained tissue oxygenation. Furthermore, the combination of CPAP with medical treatment in patients with CPE significantly reduces the need for intubation and improves the outcome.

Unfortunately, very limited data are available on the effects of CPAP in the out-of-hospital practice. Thus, we tested the potential benefit of immediate use of CPAP alone in comparison with pharmacological therapy in treatment of CPE in the acute out-of-hospital environment.

The protocol lasts 45 minutes, divided into 3 periods of 15 minutes. Patients with severe pulmonary edema are randomly assigned in 2 groups: 1/ “Early CPAP” (n=63): CPAP alone (T0-T15); CPAP + medical treatment (T15-T30); medical treatment alone (T30-T45); 2/ “Late CPAP” (n=61): medical treatment alone (T0-T15); medical treatment + CPAP (T15-T30); medical treatment alone (T30-T45). Primary endpoint : effect of early CPAP on a dyspnea clinical score and on arterial blood gases. Secondary endpoints : incidence of tracheal intubation, inotropic support, and in-hospital mortality.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Patients with clinical symptoms of acute pulmonary edema such as orthopnea, diffuse crackles without evidence of pulmonary aspiration or infection, percutaneous oxygen saturation  90% despite supplemental oxygen therapy (15 L.min-1) provided by the first responders were included in the study.

Exclusion Criteria:

  • patients with a history of chronic obstructive pulmonary disease, asthma, severe stenotic valvular disease, or if they had cardiovascular collapse or an impaired level of consciousness.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00390442

Locations
France
Lariboisiere University Hospital    
      Paris, France, 75010

Sponsors and Collaborators
Hopital Lariboisière

Investigators
Principal Investigator:     Patrick Plaisance, MD, PhD, Professor     Lariboisière Hospital    
  More Information

Study ID Numbers:   AOM03073, P030428, ENR20040504
First Received:   October 17, 2006
Last Updated:   October 17, 2006
ClinicalTrials.gov Identifier:   NCT00390442
Health Authority:   France: Delegation for Clinical Research

Keywords provided by Hopital Lariboisière:
cardiogenic pulmonary edema  
non invasive ventilation  
CPAP  

Study placed in the following topic categories:
Signs and Symptoms
Pulmonary Edema
Respiratory Tract Diseases
Lung Diseases
Edema

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers